SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $906,222 | -47.5% | 1,022,825 | -6.9% | 0.00% | – |
Q3 2022 | $1,725,000 | -71.1% | 1,098,967 | -63.0% | 0.00% | -100.0% |
Q2 2022 | $5,972,000 | -21.9% | 2,972,031 | -9.4% | 0.00% | 0.0% |
Q1 2022 | $7,645,000 | +80.0% | 3,281,214 | +259.2% | 0.00% | 0.0% |
Q4 2021 | $4,247,000 | -35.4% | 913,501 | +6.1% | 0.00% | 0.0% |
Q3 2021 | $6,572,000 | -25.7% | 861,269 | -5.7% | 0.00% | 0.0% |
Q2 2021 | $8,851,000 | +32.8% | 913,309 | +13.3% | 0.00% | 0.0% |
Q1 2021 | $6,667,000 | -49.8% | 805,985 | -58.6% | 0.00% | -50.0% |
Q4 2020 | $13,294,000 | -56.5% | 1,947,893 | -29.0% | 0.00% | -66.7% |
Q3 2020 | $30,580,000 | +444.7% | 2,742,494 | +206.8% | 0.01% | +500.0% |
Q2 2020 | $5,614,000 | +2330.3% | 893,876 | +606.9% | 0.00% | – |
Q1 2020 | $231,000 | -74.1% | 126,456 | -52.1% | 0.00% | – |
Q4 2019 | $892,000 | +350.5% | 263,854 | +183.4% | 0.00% | – |
Q3 2019 | $198,000 | +61.0% | 93,106 | +103.1% | 0.00% | – |
Q2 2019 | $123,000 | -81.2% | 45,841 | -66.7% | 0.00% | – |
Q1 2019 | $654,000 | -87.6% | 137,606 | -93.7% | 0.00% | -100.0% |
Q4 2018 | $5,258,000 | +303.8% | 2,190,901 | +639.9% | 0.00% | – |
Q3 2018 | $1,302,000 | -60.6% | 296,088 | -35.5% | 0.00% | -100.0% |
Q2 2018 | $3,303,000 | +494.1% | 458,802 | +324.7% | 0.00% | – |
Q1 2018 | $556,000 | +1058.3% | 108,023 | +744.6% | 0.00% | – |
Q4 2017 | $48,000 | +433.3% | 12,790 | +124.9% | 0.00% | – |
Q3 2017 | $9,000 | -89.7% | 5,687 | -86.9% | 0.00% | – |
Q2 2017 | $87,000 | -74.7% | 43,506 | -50.0% | 0.00% | – |
Q1 2017 | $344,000 | -67.4% | 86,970 | -59.6% | 0.00% | – |
Q4 2016 | $1,056,000 | +670.8% | 215,486 | +1118.4% | 0.00% | – |
Q3 2016 | $137,000 | +114.1% | 17,686 | +54.1% | 0.00% | – |
Q2 2016 | $64,000 | -20.0% | 11,480 | -22.2% | 0.00% | – |
Q1 2016 | $80,000 | -69.0% | 14,755 | -50.2% | 0.00% | – |
Q4 2015 | $258,000 | +106.4% | 29,632 | +98.8% | 0.00% | – |
Q3 2015 | $125,000 | -95.2% | 14,907 | -90.0% | 0.00% | -100.0% |
Q2 2015 | $2,616,000 | +1.6% | 148,429 | -33.4% | 0.00% | 0.0% |
Q1 2015 | $2,576,000 | +117.6% | 222,804 | +89.4% | 0.00% | – |
Q4 2014 | $1,184,000 | +11740.0% | 117,645 | +7743.0% | 0.00% | – |
Q2 2014 | $10,000 | +42.9% | 1,500 | +160.9% | 0.00% | – |
Q1 2014 | $7,000 | – | 575 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
Trexquant Investment LP | 67,929 | $592,000 | 0.05% |